Board changes announcement - March 2022

| Filed in:
Dr Isabelle Esser headshot

Tate & Lyle PLC (the “Company”) announces that Dr Isabelle Esser will join the Board as a non-executive director and as a member of the Remuneration and Nominations Committees on 1 June 2022.

Isabelle has over thirty years’ experience in global consumer food and ingredient companies. In more than twenty-five years with Unilever PLC, she held a range of innovation and transformation roles, finally as EVP, R&D Foods Transformation, Global Foods and Refreshment. After leaving Unilever in 2019, Isabelle became the Chief Human Resources Officer at Barry Callebaut AG, the Swiss-based global chocolate and cocoa products manufacturer. In April 2022, Isabelle will take up the role of Chief Research, Innovation and Food Quality Safety Officer at Paris-based Danone SA, a global consumer food and beverage manufacturer.

Dr Gerry Murphy, Chair of Tate & Lyle, said: “I am delighted that Isabelle has agreed to join the Board. Her scientific expertise and extensive technology leadership experience in our markets will be of significant benefit to the Board.”

There are no further disclosures to be made in connection with Dr Esser’s appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority’s Listing Rules.

END

For more information contact:

For Tate & Lyle PLC

Investors and analysts
Christopher Marsh, VP Investor Relations
Tel: Mobile: +44 (0) 7796 192 688

Media
Nick Hasell, FTI Consulting
Tel: Mobile: +44 (0) 7825 523 383

Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedinX (Twitter)Facebook or YouTube